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Background: Cardiovascular diseases remain a leading cause of the mortality world-wide, which is related to
several risks, including the life style change and the increased diabetes prevalence. The present study was to
explore the preventive effect of zinc on the pathogenic changes in the aorta.
Methods: A genetic type 1 diabetic OVE26 mouse model was used with/without zinc supplementation for 3
months. To determine gender difference either for pathogenic changes in the aorta of diabetic mice or for zinc
protective effects on diabetes-induced pathogenic changes, both males and females were investigated in parallel
by histopathological and immunohistochemical examinations, in combination of real-time PCR assay.
Results: Diabetes induced significant increases in aortic oxidative damage, inflammation, and remodeling
(increased fibrosis and wall thickness) without significant difference between genders. Zinc treatment of these
diabetic mice for three months completely prevented the above pathogenic changes in the aorta, and also
significantly up-regulated the expression and function of nuclear factor (erythroid-derived 2)-like 2 (Nrf2), a pivotal
regulator of anti-oxidative mechanism, and the expression of metallothionein (MT), a potent antioxidant. There
was gender difference for the protective effect of zinc against diabetes-induced pathogenic changes and the up-
regulated levels of Nrf2 and MT in the aorta.
Conclusions: These results suggest that zinc supplementation provides a significant protection against
diabetes-induced pathogenic changes in the aorta without gender difference in the type 1 diabetic mouse
model. The aortic protection by zinc against diabetes-induced pathogenic changes is associated with the
up-regulation of both MT and Nrf2 expression.
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Cardiovascular disease is a leading cause of mortality.
The causes of cardiovascular diseases are multifaceted,
including environmental pollution [1,2] and life style
changes such as the lack of physical activity and the in-
creased intake of Western foods that include over-
nutrition and trace elemental dyshomeostasis [3,4].* Correspondence: sugf@yahoo.com; quanliu888@163.com
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reproduction in any medium, provided the orCardiovascular diseases are sex difference. For in-
stance, men have an increased incidence and severity of
most cardiovascular diseases, including atherosclerosis,
myocardial infarction, dilated cardiomyopathy, and heart
failure, with the exception of hypertension that is higher
in women [1-4]. However, the preventive effects that
make females with a low incidence of cardiovascular dis-
eases compared to males were diminished under diabetic
conditions [5]. This may be because the vascular gender
peculiarities. For instance, animal studies showed that
endothelium-intact thoracic aortic rings from age-matched
male and female Sprague–Dawley rats were responsive to
insulin, by showing the relaxation. The hyperglycemia wasd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and apparently the female vascular endothelium is more
sensitive to the toxic effect of hyperglycemia than the male
vascular endothelium [6]. Human studies also supports the
concept that women who progressed from normoglycemia
to pre-diabetes or hyperglycemia have a greater endothelial
dysfunction, more hypertension, and a greater degree of fi-
brinolysis/thrombosis than men [7]. However, mechanisms
by which diabetes impacts more female than male remain
unclear [6,7].
Zinc (Zn) is one of the important essential trace
metals that are required for many cell events. Zn is not
only an important nutrient, cofactor of numerous en-
zymes and transcription factors, but also acts as intracel-
lular signaling mediator [8]. So far, more than 300
catalytically active Zn metalloproteinase and more than
2000 Zn dependent transcription factors have been rec-
ognized. Therefore, Zn dyshomeostasis such as Zn defi-
ciency is associated with various chronic pathogeneses,
including vascular diseases [9]. For instance, Zn defi-
ciency in endothelial cells potentiates the inflammatory
response mediated by certain lipids and cytokines, pos-
sibly via mechanisms associated with increased cellular
oxidative stress [10,11]; however, Zn supplementation
protects vascular system from oxidative damage [12,13].
One of the mechanisms by which Zn supplementation
protects vascular system from oxidative damage may in-
clude the up-regulation of NF-E2-related factor 2 (Nrf2)
expression and function [14,15]. The antioxidant respon-
sive element (ARE) is a cis-acting regulatory element of
genes encoding phase II detoxification enzymes and
antioxidant proteins, such as NAD(P)H: quinone oxido-
reductase 1 (NQO-1), HO-1, glutathione S-transferases,
and glutamate-cysteine ligase. Nrf2 regulates a wide array
of ARE-driven genes in various cell types. The DNA bind-
ing sequence of Nrf2 and ARE sequence are very similar so
that Nrf2 binds to the ARE sites leading to up-regulation
of downstream genes. Therefore, the Nrf2-ARE pathway is
important in the cellular antioxidant defense system to
protect the cell and tissue from oxidative stress, including
diabetes [16,17].
Another important potential mechanism may be the
induction of metallothionein (MT) expression [18,19].
MTs are cysteine-rich metal-binding proteins with sev-
eral biological roles including antioxidant property. We
and others have indicated the significant protection of
MT against diabetes and diabetes-induced cardiovascular
damage [19-22]. MT is ubiquitously expressed in mam-
malian tissues and also highly inducible by a variety of
reagents such as Zn; therefore, the protective effect of
Zn supplementation on diabetic heart and kidney was
noticed before [18,23,24].
Therefore, the present study was first to explore
whether diabetes-induced pathogenic changes in theaorta can be prevented by Zn supplementation, and to
compare whether there is a difference between female
and male for the preventive effect of Zn supplementa-
tion on diabetes-induced pathogenic changes in the
aorta. Then the possible mechanisms by which Zn pre-
vents the aorta from diabetes-induced pathogenic
changes were explored by analyzing Nrf2’s expression
and function, and also MT expression.
Materials and methods
Animals
OVE26 type 1 diabetic mice with FVB background were
have been used in our previous studies [25,26]. Mice
were housed in the University of Louisville Research Re-
sources Center at 22°C with a 12-h light/dark cycle and
provided with free access to standard rodent chow and
tap water. All animal procedures were approved by the
Institutional Animal Care and Use Committee, which is
certified by the American Association for Accreditation
of Laboratory Animal Care.
These OVE26 mice normally develop severe hypergly-
cemia 2 – 3 weeks after birth, and develop macro pro-
teinuria significantly at 3 month of age [27,28]. Three
months old male and female OVE26 mice were ran-
domly divided into two groups: diabetes (DM) and dia-
betes supplement with Zn (DM/Zn) with 6 mice per
group of each gender. Age- and sex-matched FVB mice
were also randomly divided into two groups: non-
diabetic control (control) and Zn control (Zn) with 6
mice in each group of each gender. For Zn and DM/Zn
mice, Zn supplementation was given by gavage at 5 mg
ZnSO4/kg every other day for 3 months while control
and DM group mice were administered with equal
amounts of saline. Volume of ZnSO4 solution was calcu-
lated based on individual rat body weight (0.1 ml
ZnSO4/g body weight). All mice from both control and
DM groups of both male and female were sacrificed at 6
months of age (i.e. Zn supplementation for 3 months).
Aorta preparation and histopathological examination
After anesthesia, thorax was opened and descending
thoracic aortas were isolated carefully and cleaned of
surrounding fat and connective tissue. Aortas tissues
were fixed in 10% buffered formalin and then cut into
ring segments (2 – 3 mm in length) for being dehydrated
in graded alcohol series, cleared with xylene, embedded in
paraffin, and sectioned at 5 μm thickness for pathological
and immunohistochemical staining. Histological evalu-
ation of aorta was performed by H&E staining with Image
Pro Plus 6.0 software for measuring the means of the tu-
nica media width size as the thickness of aortic tunica
media.
Paraffin sections (5 μm thickness) from aortic tissues
were dewaxed and incubated with 1X Target Retrieval
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15 min at 98°C for antigen retrieval, with 3% hydrogen
peroxide for 15 min at room temperature, and then with
5% animal serum for 30 min, respectively. These sections
were incubated with primary antibodies against connect-
ive tissue growth factor (CTGF) and transforming growth
factor (TGF)-β1 at 1:100 dilution (Santa Cruz Biotechnol-
ogy, Santa Cruz, CA), 3-nitrotyrosine (3-NT) at 1:400
dilution (Millipore, Billerica, CA), 4-hydroxy-2-nonenal
(4-HNE) at 1:400 dilution (Alpha Diagnostic International,
San Antonio, TX), Collagen IV at 1:200 dilution (Santa
Cruz Biotechnology, Santa Cruz, CA), plasminogen activa-
tor inhibitor-1 (PAI-1) at 1:100 dilution (BD Bioscience,
San Jose, CA), tumor necrosis factor-α (TNF-α, Abcam,
Cambridge, MA) at 1:100 dilution, nuclcar- associated
antigen ki-67 at 1:400 dilution (Abcam, Cambridge, MA),
MT at 1:100 dilution (DakoInc, Carpinteria, CA), NADPH
quinine oxidoreductase (NQO-1) at 1:200 dilution (Cell
Signaling, MA), Nrf2at 1:100 dilution, and vascular cell
adhesion molecule 1 (VCAM-1) at 1:100 dilution (both
from Santa Cruz Biotechnology) overnight at 4°C. After
sections were washed with PBS, they were incubated with
horseradish peroxidase conjugated secondary antibodies
(1:300 – 400 dilutions with PBS) or Cy3-coupled goat
anti-rabbit IgG secondary antibody for 2 h in room
temperature. For the color development of immunohisto-
chemical staining sections were treated with peroxidase
substrate DAB kit (Vector Laboratories, Inc. Burlingame,
CA) and counterstained with hematoxylin. For immuno-
fluorescent staining sections were stained with DAPI at
1:1000 dilution to localize the nucleus.
For quantitative analysis of these immunohistochemi-
cal staining, three sections at interval of 10 sections
from each aorta (per mouse) were selected and at least
five high-power fields were randomly captured per sec-
tion. Image Pro Plus 6.0 software was used to transfer
the interesting area staining density to an integrated op-
tical density (IOD) that was divided by the area size of
interest to reflect the staining level of the area of inter-
est, and the ratio of IOD/area size in experimental group
was presented as a fold relative to that of control. For Ki-67
staining, the positively stained nuclei were counted randomly
in five microscopic fields at least of each of the three slides
per aorta (mouse) under light microscopy. The percentage
of positive staining nuclei in total 100 nuclei was presented.
Sirius-red staining for collagen
Aortic fibrosis was reflected by Sirius-red staining for
collagen, as described in our previous study [21]. Briefly,
5 μm tissue sections were used for Sirius-red staining
with 0.1% Sirius-red F3BA and 0.25% Fast Green FCF.
Sections stained for Sirius-red then were assessed for the
proportion of collagen using a Nikon Eclipse E600 mi-
croscopy system.TUNEL staining
Terminal deoxynucleotidyl-transferase-mediated dUTP-
nick-end labeling (TUNEL) staining was performed on
formalin-fixed, paraffin-embedded sections with Perox-
idase In Situ Apoptosis Detection Kit S7100 (Millipore,
Billerica, MA) according to the instructions. The posi-
tively stained apoptotic cells were counted randomly in
five microscopic fields at least of each of the three slides
per aorta (mouse) under light microscopy. The percent-
age of TUNEL positive cells relative to 100 nuclei was
presented.
Real-time qPCR
Collected aortas were snap frozen in liquid nitrogen and
kept at - 80°C. Total RNA was extracted using the TRIzol
Reagent (Invitrogen, USA). RNA concentrations and pu-
rities were quantified using a Nanodrop ND-1000 spectro-
photometer. First-strand complimentary DNA (cDNA) was
synthesized from total RNA according to manufacturer’s
protocol from the RNA PCR kit (Promega, Madison, WI).
Reverse transcription was performed using 0.5 μg of total
RNA in 12.5 μl of the solution containing 4 μl 25 mM
MgCl2, 4 μl AMV reverse transcriptase 5 X buffer, 2 μl
dNTP, 0.5 μl RNase inhibitor, 1 μl of AMV reverse tran-
scriptase, and 1 μl of oligodT primer, which were added
with nuclease-free water to make a final volume of 20 μl.
Reaction system was run at 42°C for 50 min and 95°C for 5
min. Primers of TNF-α, Nrf2, MT, NQO-1, and β-actin
were purchased from Applied Biosystems (Carlsbad, CA).
Real-time quantitative PCR (qPCR) was carried out in a 20
μl reaction buffer that included 10 μl of TaqMan Universal
PCR Master Mix, 1 μl of primer, 9 μl of cDNA with the
ABI 7300 Real-Time PCR system. The fluorescence inten-
sity of each sample was measured at each temperature
change to monitor amplification of the target gene. The
comparative cycle time (CT) was used to determine fold
differences between samples.
Statistical analysis
Data were collected from several animals (n = 6) and
presented as means ± SD. We used Image Pro Plus 6.0
software to measure the pathological changes, as de-
scribed above. Comparisons were performed by one-way
ANOVA for the different groups, followed by post hoc
pairwise repetitive comparisons using Tukey’s test with
Origin 7.5 Lab data analysis and graphing software. Stat-
istical significance was considered as P <0.05.
Results
Preventive effect of Zn on diabetes-induced aortic fibrosis
OVE26 transgenic diabetic mice and age-matched FVB
mice both male and female were treated with Zn for 3
months. Aortas were examined pathologically with H&E








































































Figure 1 Preventive effect of Zn on diabetes-induced aortic pathological changes. The pathogenic changes of aortas were examined by
H&E staining (A), and Sirius-red staining for collagen accumulation (B), followed with semi-quantitative analysis. Data were presented as means ±
SD (n = 6). *, p < 0.05 vs. Corresponding Control; #, p < 0.05 vs. Corresponding DM. Bar = 50 μM.
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male and female. Similarly Sirius-red staining revealed
an increased collagen accumulation in aortic tunica
media of diabetic mice (Figure 1B). Both pathological al-
terations were completely prevented by Zn supplementa-
tion in DM/Zn group without gender difference.
To further examine the preventive effect of Zn on
diabetes-induced aortic fibrosis, immunohistochemical
staining showed the increased expression of pro-fibrotic
mediators, CTGF and TGF-β1, and collagen IV accumu-
lation, in aortic tunica media of diabetic mice without
gender difference (Figure 2). Supplementation with Zn
could completely prevent these fibrotic responses in the
aortas of diabetic mice (DM/Zn group).Preventive effect of Zn on diabetes-induced aortic
inflammation and oxidative damage
Immunohistochemical staining showed a significant in-
crease in aortic expression of inflammatory markers
VCAM-1 (Figure 3A) and PAI-1 (Figure 3B) in the aortic
tunica media of diabetic mice for both genders. Supple-
mentation with Zn can completely prevent the inflam-
mation response in aortas of diabetic mice (DM/Zn
group). We also examined the expression of TNF-α as
an important inflammatory factor at mRNA (Figure 4A)
and protein (Figure 4B-D) levels, which shows that a sig-
nificant increase in aortic expression of TNF-α at both
mRNA and protein levels in the aortic tunica media of
diabetic mice without gender difference. This effect wascompletely prevented by supplementation with Zn in
diabetic mice (DM/Zn group).
In addition, a significantly increased accumulation of
oxidative and nitrative damage, 4-HNE (Figure 5A) and
3-NT (Figure 5B), was also evident in aortic tunica
media of diabetic mice, but not in Zn-treated diabetic
mice (DM/Zn group).Preventive effect of Zn on diabetes-induced aortic
apoptotic cell death and proliferation
Diabetes was found to induce an increase in the apoptotic
cell death, reflected by TUNEL positive cells (Figure 6A)
and cell proliferation, reflected by Ki-67 positive nuclear
(Figure 6B) in the aorta of both male and female diabetic
mice (DM group), but not in Zn-treated diabetic mice
(DM/Zn group).Up-regulation of Nrf2 expression and its downstream
antioxidant gene expression by Zn in the aorta
Aortic Nrf2 expression was examined by real-time qPCR
for its mRNA level (Figure 7A) and immunofluorescent
staining for its protein level (Figure 7B,C), followed by
semi-quantitative analysis (Figure 7D). The qPCR ana-
lysis showed that diabetes significantly increased aortic
expression of Nrf2 at mRNA levels; an effect was not
seen in Zn-treated normal mice. Interestingly Zn treat-
ment also did not significantly affect diabetes-induced
Nrf2 mRNA expression. However, immunofluorescent

































































































Figure 2 Preventive effect of Zn on diabetes-induced aortic fibrosis. Aortic fibrosis was examined by immunohistochemical staining for the
expression of CTGF (A), TGF-β1 (B) and Collagen IV (C), followed with semi-quantitative analysis. Data were presented as means ± SD (n = 6).
*, p < 0.05 vs. Corresponding Control; #, p < 0.05 vs. Corresponding DM. Bar = 50 μM.
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level (Figure 7B-D).As a result, the DM/Zn group, which
had both the diabetes and the Zn treatment, had the highest
aortic content of Nrf2 protein among all the groups. Fur-
thermore, Figures 7B,C also show an increased accumula-
tion of Nrf2 predominantly in the nuclei, suggesting the
potential increase in its transcriptional function.
To support the up-regulation of Nrf2 transcriptional
function, qPCR analysis shows that one of Nrf2 down-
stream genes, NQO1, was significantly increased at its
mRNA level in the aorta of Zn, DM, and DM/Zn groups
with the highest expression in the DM/Zn group
(Figure 8A). The up-regulated mRNA expression of
NQO-1 was accompanied with a significant increase in
its protein expression (Figure 8B-D). There was no gen-
der difference for either NQO-1 mRNA expression or its
protein expression.
Up-regulation of MT mRNA and protein expression by Zn
in the aorta
Since several studies have proposed the potential role of
MT in Zn cardiac and renal protection against diabetes[18,23,24,29], we next examined the MT expression at
both mRNA and protein levels in the aorta. Zn supple-
mentation to control mice significantly increased the
aortic expression of MT at mRNA level (Figure 9A),
along with an increased expression of MT protein
(Figure 9B-D) in the aorta of both male and female mice,
compared with untreated control. However, diabetes sig-
nificantly decreased the expression of MT mRNA and
protein (Figure 9) while Zn treated diabetic mice pre-
served MT mRNA and protein expression levels com-
parable to control level (Figure 9).
Discussions
In the present study, we have explored, for the first time,
the protective effect of Zn supplementation on diabetes-
induced pathogenic changes in the vessel, particularly in
the aorta of genetic type 1 diabetic OVE26 mice. We
found significant increases in aortic oxidative damage,
inflammation, fibrosis and thickness in OVE26 mice,
which was completely prevented by Zn treatment for 3
months. Mechanistic studies showed that the aortic pro-













































































Figure 4 Preventive effect of Zn on diabetes-induced aortic TNF-α expression. Aortic expression of TNF-α was examined by real-time PCR
for its mRNA level (A) and immunohistochemical staining for its protein expression in aortic tunica media (B for male and C for female), followed
by semi-quantitative analysis (D for both male and female). Data were presented as means ± SD (n = 6).*, p < 0.05 vs. Corresponding Control; #,






























































Figure 3 Preventive effect of Zn on diabetes-induced aortic inflammation. Aortic inflammation was examined by immunofluorescent
staining for the expression of VCAM-1(A) (red) and immunohistochemical staining for the expression of PAI-1 (B), followed by semi-quantitative
analysis. Data were presented as means ± SD (n = 6).*, p < 0.05 vs. Corresponding Control; #, p < 0.05 vs. Corresponding DM. Bar = 50 μM.






















































Control Zn DM DM/ZnB
Figure 5 Preventive effect of Zn on diabetes-induced aortic oxidative damage. The oxidative damage was examined by
immunohistochemical staining for the accumulation of 4-HNE (A) and 3-NT (B), followed with semi-quantitative analysis. Data were presented as
means ± SD (n = 6).*, p < 0.05 vs. Corresponding Control; #, p < 0.05 vs. Corresponding DM. Bar = 50 μM.
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http://www.cardiab.com/content/12/1/54pathogenesis was associated both with the up-regulation
of Nrf2 protein expression and transcription, shown by
the increased expression of Nrf2 down-stream gene
NQO-1 at both mRNA and protein levels, and with the
up-regulation of MT expression.
Zn plays important roles in the protection of vascular
system from oxidative stress and damage. For instance,
Zn deficiency in diabetic patients was found to associate




















Figure 6 Diabetes induced aortic apoptosis and proliferation increase
with semi-quantitative analysis. And the proliferation of aortic tunica media
cells (B), followed with semi-quantitative analysis. Data were presented as m
Corresponding DM. Bar = 50 μM.related to the increased inflammatory response in system
and vascular system [31-34]. Chronic inflammation plays
a critical role for the development of various chronic
pathogeneses [35-38]. The effects of chronic inflamma-
tion include induction of oxidative stress, apoptotic cell
death, and abnormal cell proliferation, all which could
contribute to the tissue structural and functional abnor-
malities [35-38]. In the present we demonstrated the in-






















































d. The apoptotic cell was examined by TUNEL staining (A), followed
was examined by immunohistochemical staining for ki-67 positive

























































Control Zn DM DM/Zn D
Figure 7 Effects of Zn on aortic expression of Nrf2. Aortic expression of Nrf2 was examined by real-time PCR for its mRNA level (A) and
immunohistochemical staining for its protein expression (red) in aortic tunica media (B for male and C for female) with semi-quantitative analysis
(D for both male and female).Data were presented as means ± SD (n = 6).*, p < 0.05 vs. Corresponding Control; #, p < 0.05 vs. Corresponding DM.
Bar = 50 μM.
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http://www.cardiab.com/content/12/1/54expression of TNF-α, VACM-1 and PAI-1 in the aorta of
DM, which was accompanied with increased aortic oxi-
dative stress, apoptotic cell death, cell proliferation, and
remodeling in DM group. All these pathogenic changes
were prevented by Zn supplementation.
In contrast to Zn deficiency, Zn supplementation was
found beneficial for the patients with various cardiovas-
cular diseases [11,14,39-43]. Recently we also reported













































Figure 8 Effects of Zn on aortic expression of Nrf2 downstream gene
examined by real-time PCR at mRNA level (A) and immunohistochemical s
for female) with semi-quantitative analysis (D for both male and female).Da
Control; #, p < 0.05 vs. Corresponding DM. Bar = 50 μM.sulforaphane in a type diabetic mouse model, in which,
however, we have used streptozotocin (STZ) to induce
diabetic mouse model [44], as used most frequently by
others [45-48]. However, in STZ-induced diabetic animals
STZ may have direct toxic effects on multiple organs [49].
Compared to STZ-induced diabetic mice, OVE26 mice
exhibit more characteristics of human diabetic nephropa-
thy, showing the time-dependent proteinuria [28,50,51].



































s. Aortic expression of Nrf2 down-stream genes NQO-1 expression was
taining for protein expression in aortic tunica media (B for male and C








































































Figure 9 Effects of Zn on aortic expression of MT. Aortic expression of MT expression was examined by real-time PCR for its mRNA level (A)
and immunohistochemical staining for its protein expression in aortic tunica media (B for male and C for female), followed with semi-quantitative
analysis (D for both male and female).Data were presented as means ± SD (n = 6).*, p < 0.05 vs. Corresponding Control; #, p < 0.05 vs.
Corresponding DM. Bar = 50 μM.
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plementation from diabetes-induced pathogenic dam-
ages, including oxidative damage, inflammation and
fibrotic response.
In the present study we used both male and female
mice to compare whether there is gender difference for
the pathogenic changes in the aorta. No difference was
found either for the pathogenic change in the aorta in-
duced by diabetes or the preventive effect of Zn on
diabetes-induced pathogenic changes in the aorta. Inter-
estingly a previous study compared the impact of gender
on cardiac contractile response in ventricular myocytes
from wild-type FVB and OVE26 mice at young (2
month) and older (11 month) age [52]. They found that
OVE26 myocytes displayed reduced peak shortening
(PS) and maximal velocity of shortening/relengthening
(+/− dL/dt), and prolonged time-to-PS and time-to-90%
relengthening, associated with higher resting intracellu-
lar Ca2+ levels and attenuated Ca(2+)-induced intracel-
lular Ca2+ release compared with the FVB myocytes.
Peak shortening and +/− dL/dt were smaller in female
FVB groups when compared to the age-matched male
counterparts. However, these gender differences were
significant at 2 month old mice, but not at 11 month old
mice. Therefore, mechanical differences existed between
genders but were “cancelled off” by diabetic state. Never-
theless, a “female advantage” in ventricular function may
still persist in young female diabetic subjects [52].
Therefore, the age of OVE26 mice used here may ex-
plain the lack of gender impact on diabetes-inducedpathogenic changes and its protection by Zn since these
mouse ages are 6 months old.
One important mechanism by which Zn protects the
aorta from diabetes may be related to the up-regulation of
Nrf2 in the aorta. Recently the important protection by
Nrf2 from diabetes in various organs, including the heart
and kidney, has been extensively reported [17,53,54].
There were several reports to indicate the possible induc-
tion of Nrf2 and its down-stream antioxidant genes by Zn
[14,15,55]. However, here we provided the first evidence
to indicate the Zn protection against diabetes-induced
pathogenic changes in the aorta of diabetic mice treated
with Zn for 3 months, probably associated with the up-
regulation of Nrf2 expression and function.
One of the novel findings in the present study is the
difference for Nrf2 expression in the aorta of mice in re-
sponse to diabetes and Zn. Nrf2 protein level (about 3
fold increase) is significantly lower than mRNA level
(about 6 fold increase) in diabetes group, suggesting the
increase of Nrf2 degradation, resulting in only about 3
fold increase in protein level. In contrast, Zn treatment
did not increase Nrf2 mRNA level, but increased Nrf2
protein level to about 3 fold higher than control,
suggesting Zn’s stabilization of Nrf2, which also explain
why in DM/Zn group the Nrf2 expression is about 6
fold, since it is the combined outcome of the diabetic in-
duction of Nrf2 mRNA and Zn stabilization of Nrf2
protein.
How Zn stabilizes Nrf2 protein level remains unclear,
however, there was an interesting report that supports
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in rats decreases Zn levels and macrophage function in
the alveolar space, which was accompanied with a de-
crease in Nrf2 nuclear binding capacity, i.e.: Nrf2 func-
tion decrease. When these rats were supplemented with
Zn, Zn deficiency was corrected, resulting in a restor-
ation of Nrf2 nuclear banding capacity along with a pre-
vention of alcohol-induced macrophage function in the
alveolar space of these rats [55]. This study suggests the
requirement of Zn for maintaining normal function of
Nrf2 in certain conditions.
However, a question is why the increased pathologic
change was still observed in the aorta of OVE26 diabetic
mice that also showed a significant increase in aortic
Nrf2 expression. We assumed that the expression of
Nrf2 and its downstream antioxidants in the aortas of
diabetic mice is an adaptive response to diabetes. There-
fore, the increased level in DM group that is significantly
less than that in DM/Zn group may be not enough to
rescue all injuries. However, although this adaptive re-
sponse is unable to completely prevent, it should still
protect certain levels of pathogenic damage induced by
diabetes; otherwise these pathogenic changes would be
more severe and appear earlier.
In addition, Zn protection from diabetes-induced aortic
injury may also include other possible mechanisms. One
most likely alternative mechanism may be the induction
of MT since MT’s anti-oxidative protection from various
conditions, including diabetes, has been extensively
reported, even in our own laboratory [18,29,56-59]. Here
we provide the first evidence that Zn induced, and dia-
betes decreased, the MT mRNA expression in the aorta,
but Zn treatment can preserve the MT mRNA expression
to control level in the OVE26 mice. In contrast to aortic
Nrf2 or NQO-1 expression that was also up-regulated in
diabetic group, aortic MT expression was significantly de-
creased in DM group, but not in DM/Zn group.
Although there was no much information regarding
the role of MT in vascular function under diabetic con-
dition, a few studies related it under other conditions
also support the important role of MT in maintenance
of normal vascular structure and function [60,61]. For
instance, Zn protection from high-level glucose (HG), a
diabetes feature on culture cardiomyocytes was observed
recently [60]. The authors demonstrated that extracellu-
lar Zn2+ reduced cardiomyocyte contractile function in
both HG and control groups, but enhanced relaxation
function significantly in the HG group compared to con-
trols. Most notably, a reduction in diastolic sarcomere
length with increasing pacing frequencies, i.e., incom-
plete relaxation, was more pronounced in the HG com-
pared to controls, but was normalized with extracellular
Zn2+ application, implicating that the detrimental effect
of HG on cardiomyocyte Ca2+ regulation can beamelioration by Zn2+ [60]. Since MT was not measure in
these cells, we do not know whether MT is involved in
the beneficial effect of Zn. In another in vivo study, the
effect of MT on collaterogenesis was demonstrated be-
tween mice with MT gene deletion and wild-type mice
[61]. They found that mice defect in MT gene expression
have impaired collateral flow recovery after the induc-
tion of acute hind limb ischemia. They further demon-
strated that endothelial cells, smooth muscle cells, and
macrophages that are known to be involved in collateral
remodeling were dysfunctional in MT gene deficient
mice. All these studies imply that MT plays an import-
ant role in maintaining the normal structure and func-
tion of vascular cells and vessels. Zn beneficial effect on
vascular cells and/or vessels maybe related to MT ex-
pression, which need to further study in the future.
A potential limitation of the present study is that the
most results are based on the immunohistochemical
staining and real-time PCR assays. For the protein ex-
pression, this study will be greatly strengthened if we
could have enough tissues to perform Western blotting
assay. This will be warranted in the further study.
Conclusions
In summary, we demonstrated here that Zn supplemen-
tation provides a significant protection against diabetes-
induced pathogenic changes in the aorta without gender
difference in the type 1 diabetic mouse model. The aor-
tic protection by Zn against diabetes-induced pathogenic
changes is associated with the up-regulation of both
Nrf2 and MT expression.
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